CTX213 Trademark

Serial Number: 98955696

CTX213 is a trademark filed by CRISPR Therapeutics AG on January 13, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Legal Representation

Attorney of Record

Tiffany D. Gehrke

979 trademarks filed View all →

Correspondence Address

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP

233 South Wacker Drive, Suite 6300

Chicago, IL 60606

United States

Trademark Details

Filing Date

January 13, 2025

Registration Date

Not Registered

Published for Opposition

July 29, 2025

Goods & Services

gene editing, namely, pharmaceutical research and development in the field of stem cell therapy for the treatment of diabetes; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of stem cell therapy for the treatment of diabetes

Cells for medical or clinical use in the field of stem cell therapy for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes; pharmaceutical and biopharmaceutical agents for the treatment of diabetes